Company Search:
Advanced Search
Sponsored Links
Bergenbio ASA Company Snapshot
Bergenbio ASA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bergenbio ASA with three other miscellaneous service companies in Europe: Ryvu Therapeutics SA of POLAND (2019 sales of 3.80 million Polish New Zlotys [US$1.01 million] of which 100% was Innovative), Active Biotech AB (publ) of SWEDEN (8.43 million Swedish Kronor [US$991,791.00 ] of which 58% was Rental revenues), and Medivir AB which is also based in SWEDEN (8.72 million Swedish Kronor [US$1.03 million] of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bergenbio ASA
  Stock Performance Chart for Bergenbio ASA
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 27.70
(Figures in Norwegian Kroner)
1 Week -6.4%   13 Weeks -3.1%  
4 Weeks -18.4%   52 Weeks 80.0%  
Bergenbio ASA Key Data:
  Ticker: BGBIO Country: Norway
  Exchanges: OSL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 8,900,000
(Year Ending Jan 2020).
Employees: 26
  Currency: Norwegian Kroner Market Cap: 2,417,101,529
  Fiscal Yr Ends: December Shares Outstanding: 87,259,983
  Share Type: ORDINAERE AKSJE Closely Held Shares: 33,781,465
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.